Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael Gottardo

Showing results (131-140 of 187) with videos related to

Pageof 19
Sort By:
Msphere|June 13, 2022
Monocyte Transcriptional Responses to Mycobacterium tuberculosis Associate with Resistance to Tuberculin Skin Test and Interferon Gamma Release Assay ConversionJason D Simmons, Kimberly A Dill-McFarland, Catherine M Stein, et al.
Nature Immunology|November 1, 2022
Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responsesThomas Hagan, Bram Gerritsen, Lewis E Tomalin, et al.
Nature Communications|February 22, 2019
Integrated systems approach defines the antiviral pathways conferring protection by the RV144 HIV vaccineSlim Fourati, Susan Pereira Ribeiro, Filipa Blasco Tavares Pereira Lopes, et al.
Ebiomedicine|January 20, 2015
Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting VirusesSusan Zolla-Pazner, Paul T Edlefsen, Morgane Rolland, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|October 9, 2015
A benchmark for evaluation of algorithms for identification of cellular correlates of clinical outcomesNima Aghaeepour, Pratip Chattopadhyay, Maria Chikina, et al.
The Journal of Clinical Investigation|June 10, 2021
Monocyte metabolic transcriptional programs associate with resistance to tuberculin skin test/interferon-γ release assay conversionJason D Simmons, Phu T Van, Catherine M Stein, et al.
Cancer Cell|December 28, 2020
Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint BlockadeShivani Srivastava, Scott N Furlan, Carla A Jaeger-Ruckstuhl, et al.
Plos Pathogens|June 27, 2020
Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II TrialYves Lévy, Christine Lacabaratz, Kim Ellefsen-Lavoie, et al.
Medrxiv : the Preprint Server for Health Sciences|January 7, 2025
Acute Myeloid Leukemia Skews Therapeutic WT1-specific CD8 TCR-T Cells Towards an NK-like Phenotype that Compromises Function and PersistenceFrancesco Mazziotta, Lauren E Martin, Daniel N Eagan, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2024
Tumor Regression Following Engineered Polyomavirus-Specific T Cell Therapy in Immune Checkpoint Inhibitor-Refractory Merkel Cell CarcinomaYuta Asano, Joshua Veatch, Megan McAfee, et al.
Pageof 19

Showing results (131-140 of 187) with videos related to

Sort By:
Pageof 19
Msphere|June 13, 2022
Monocyte Transcriptional Responses to Mycobacterium tuberculosis Associate with Resistance to Tuberculin Skin Test and Interferon Gamma Release Assay ConversionJason D Simmons, Kimberly A Dill-McFarland, Catherine M Stein, et al.
Nature Immunology|November 1, 2022
Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responsesThomas Hagan, Bram Gerritsen, Lewis E Tomalin, et al.
Nature Communications|February 22, 2019
Integrated systems approach defines the antiviral pathways conferring protection by the RV144 HIV vaccineSlim Fourati, Susan Pereira Ribeiro, Filipa Blasco Tavares Pereira Lopes, et al.
Ebiomedicine|January 20, 2015
Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting VirusesSusan Zolla-Pazner, Paul T Edlefsen, Morgane Rolland, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|October 9, 2015
A benchmark for evaluation of algorithms for identification of cellular correlates of clinical outcomesNima Aghaeepour, Pratip Chattopadhyay, Maria Chikina, et al.
The Journal of Clinical Investigation|June 10, 2021
Monocyte metabolic transcriptional programs associate with resistance to tuberculin skin test/interferon-γ release assay conversionJason D Simmons, Phu T Van, Catherine M Stein, et al.
Cancer Cell|December 28, 2020
Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint BlockadeShivani Srivastava, Scott N Furlan, Carla A Jaeger-Ruckstuhl, et al.
Plos Pathogens|June 27, 2020
Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II TrialYves Lévy, Christine Lacabaratz, Kim Ellefsen-Lavoie, et al.
Medrxiv : the Preprint Server for Health Sciences|January 7, 2025
Acute Myeloid Leukemia Skews Therapeutic WT1-specific CD8 TCR-T Cells Towards an NK-like Phenotype that Compromises Function and PersistenceFrancesco Mazziotta, Lauren E Martin, Daniel N Eagan, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2024
Tumor Regression Following Engineered Polyomavirus-Specific T Cell Therapy in Immune Checkpoint Inhibitor-Refractory Merkel Cell CarcinomaYuta Asano, Joshua Veatch, Megan McAfee, et al.
Pageof 19